Rohto Advanced Research Hong Kong
Company details Rohto Advanced Research Hong Kong Limited (RARHK) is a newly established company in January 2019 by Rohto Pharmaceutical Co., Ltd (ROHTO) in Japan. The core businesses of ROHTO are cosmetics, pharmaceutical products and functional foods. ROHTO has advantages in terms of basic research, such as cell culture techniques, and manufacturing, utilizing aseptic automated manufacturing system for eye drops.   Regenerative medicine is one of the focusing areas in ROHTO. A Phase 1/2 study of allogenic adipose-derived mesenchymal stromal cells against liver cirrhosis is under way in Japan.   In accordance with the strategic planning and development of regenerative medicine and its related businesses, RARHK will take over the advantages and cutting-edge technologies of ROHTO. RARHK will conduct basic research on mesenchymal stromal cells and other possible candidate(s) for the upcoming new era of cell therapies.    More laboratory information is available in the website:
Copyright © 2017 Limited. All Rights Reserved.
收藏該職位 取 消